Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-75
SponsorNanjing University of Traditional Chinese Medicine

About this trial

This study intends to further evaluate the efficacy of acupuncture by comparing the intervention effects of different acupuncture treatment regimens on hot flashes in breast cancer ; and to explore the central effect regulation mechanism of acupuncture intervention on hot flashes based on functional magnetic resonance imaging technology.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18-75 years old;

Adjuvant hormone therapy (eg, tamoxifen and/or aromatase inhibitors) with or without ovarian function suppression has been administered for at least 4 weeks and is currently on treatment;

Vasomotor syndrome for at least 6 weeks;

Premenopausal or postmenopausal patients;

Disqualifiers

Tumor metastases, undergoing chemoradiotherapy or planning surgery;

Pharmacological intervention for hot flashes with hot flash treatment drugs such as selective serotonin reuptake inhibitors (SSRIs) and/or anticonvulsants for at least 4 weeks prior to study initiation;

Unstable heart disease or myocardial infarction within 6 months prior to study start;

Started or changed adjuvant hormone therapy within the past week, or who planned to start or change adjuvant hormone therapy in the past 14 weeks;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Acupuncture treatment

    Other intervention

    Acupoint selection: Hegu-Yinxi acupoint group (clearing heat and relieving sweat), Sanyinjiao-Fuliu acupoint group (nourishing yin and tonifying kidney), Tianshu-uteri acupoint group (special effect points) (12 acupoints on both sides). Frequency: 3 times a week (once every other day) for a total of 8 weeks of continuous treatment. Operation: Use a one-time sterile acupuncture needle (0.30×40mm, Huatuo brand), insert the needle 0.5 inch along the anatomical position, level up and relieve the qi, and keep the needle for 20 minutes.

  • Sham Acupuncture treatment

    Other intervention

    Selecting acupoints: Select the side opening positions of the 6 acupuncture points in the real acupuncture group, and select non-meridian and non-points (points with less nerve distribution, sparseness, and rich muscles). Frequency: 3 times a week (once every other day) for a total of 8 weeks of continuous treatment. Operation: ① Shallow needling scheme: use a disposable sterile acupuncture needle, insert the needle 0.2 inch, without twisting, and keep the needle for 20 minutes. ②Non-invasive acupuncture plan: choose a special comfort needle with no needle tip at the top of the needle, paste a disposable sterile foam pad on the non-acupoint, and use a disposable sterile flat head The acupuncture needles were pierced into the foam pad, lightly touching but not piercing the skin, and not breathing; the needles were kept for 20 minutes.

Treatment groups

90 Participants
are divided into 3 treatment groups
Group A: Treatment group AExperimental treatment 1 intervention
Group B: Treatment group BSham comparator 1 intervention
Group C: controlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Change in cancer therapy functional assessment

Cancer therapy functional assessment scores will be assessed with Cancer Therapy Functional Assessment-Breast cancer, version 4.The minimum value is 0 , and the maximum value is 185. The higher scores mean a worse outcome.

Time frame
Baseline, 8,24 weeks later
2

Change in acupuncture efficacy expectation assessment

Acupuncture efficacy expectation assessment scores will be assessed with acupuncture efficacy expectation assessment. The minimum value is 0 , and the maximum value is 20. The higher scores mean a better outcome.

Time frame
Baseline, 8,24 weeks later
3

Change of functional connectivity of whole brain

Functional connectivity will be measured with magnetic resonance imaging based on blood oxygen level dependence.

Time frame
Baseline, 8,24 weeks later
4

Change of metabolism of glucose in the brain

Accumulation of 18F-fluorodeoxyglucose(18F-FDG) will be analyzed by time-related Positron emission tomography.

Time frame
Baseline, 8,24 weeks later

Secondary outcomes

1

Change in sleep

Sleep scores will be assessed with Pittsburgh sleep quality index.The minimum value is 9, and the maximum value is 36. The higher scores mean a worse outcome.

Time frame
Baseline, 8,24 weeks later

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: